Traws Pharma, Inc.
New Filing
CIK: 0001130598·Biotechnology·DELAWARE·Filed: Apr 16, 2024
Total Offering
$14,000,000
Amount Sold
$14,000,000
Investors
2
First Sale
Apr 1, 2024
Offering Details
- Type
- Other: Shares of Common Stock and Series C Preferred Stock
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Werner Cautreels | Related Person |
| Steven Fruchtman | Related Person |
| Mark Guerin | Related Person |
| Robert Redfield | Related Person |
| David Pauza | Related Person |
| Ian Dukes | Related Person |
| Nikolay Savchuk | Related Person |
| Trafford Clarke | Related Person |
| James Marino | Related Person |
| M. Theresa Shoemaker | Related Person |
| Jack E. Stover | Related Person |
Company
SEC Filing
0000929638-24-001481
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free